Use of rituximab in pemphigus patients with chronic viral hepatitis: Report of three cases.
Indian J Dermatol Venereol Leprol
;
2014 Spt-Oct ; 80 (5): 422-426
Artigo
em Inglês
| IMSEAR
| ID: sea-154925
ABSTRACT
Use of rituximab in patients with chronic viral hepatitis can worsen pre-existing hepatitis or reactivate occult infection. There are no reports of use of rituximab in pemphigus patients with co-existing viral hepatitis. Herein, we report three pemphigus patients with co-existing chronic viral hepatitis (hepatitis C (n = 2), hepatitis B (n = 1)), who were treated successfully with rituximab under close supervision and concurrent antiviral drug administration. There was no derangement of the liver function tests or increase in viral load in any of the patients. By incorporating good collaboration with a hepatologist and close follow-up, such patients can be managed successfully with biologic therapies when the conventional treatment modalities have failed.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Antivirais
/
Feminino
/
Humanos
/
Masculino
/
Pênfigo
/
Adulto
/
Hepatite B Crônica
/
Hepatite C Crônica
/
Fármacos Dermatológicos
/
Anticorpos Monoclonais Murinos
Idioma:
Inglês
Revista:
Indian J Dermatol Venereol Leprol
Ano de publicação:
2014
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS